Search

47:03","modified_gmt":"2017-07-17T09:47:03","slug":"human-antibodies-developed-for-treatment-of-lupus-and-anthrax","status":"publish","type":"post","link":"https://www2.mrc-lmb.cam.ac.uk/ ... n. The drug candidatesu2014belimumab (BENLYSTATM, formerly

{"id":4193,"date":"2013-01-07T13:50:34","date_gmt":"2013-01-07T13:50:34","guid":{"rendered":"http://www2.mrc-lmb.cam.ac.uk/wordpress/research/technology-transfer/history-of-technology-transfer/"},"modified":"2023-07-21T12:49:41","modified_gmt":"2023-

21 Jul 2023: This antibody, for treatment of rheumatoid arthritis, proved a blockbuster drug with total sales of more than $10 billion by the end of 2009. ... Other antibodies followed, including BENLYSTA, which promises to be the first new drug treatment for

11 Mar 2011: Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems. ... Food and Drug

for treatment of lupus. ... Published on. 11 March, 2011. Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating fatigue, painful and swollen joints, fever, skin rash, and kidney problems.

approved-for-treatment-of-lupus/","title":{"rendered":"Human antibody approved for treatment of lupus"},"content":{"rendered":". Systemic lupus erythematosus is a chronic, life-threatening inflammatory autoimmune disease that can cause debilitating

31 Jul 2009: The drug candidates—belimumab (BENLYSTATM, formerly LumphoStat-B), developed by Human Genome Sciences with GlaxoSmithKine as a treatment for systemic lupus erythematosus and raxibacumab (ABthrax), developed by Human Genome Sciences as ... Systemic